TY - JOUR
T1 - Bcl10 and MALT1, Independent Targets of Chromosomal Translocation in MALT Lymphoma, Cooperate in a Novel NF-κB Signaling Pathway
AU - Lucas, Peter C.
AU - Yonezumi, Masakatsu
AU - Inohara, Naohiro
AU - McAllister-Lucas, Linda M.
AU - Abazeed, Mohamed E.
AU - Chen, Felicia F.
AU - Yamaoka, Shoji
AU - Seto, Masao
AU - Núñez, Gabriel
PY - 2001/6/1
Y1 - 2001/6/1
N2 - At least two distinct recurrent chromosomal translocations have been implicated in the pathogenesis of MALT lymphoma. The first, t(1;14), results in the transfer of the entire Bcl10 gene to chromosome 14 wherein Bcl10 expression is inappropriately stimulated by the neighboring Ig enhancer. The second, t(11;18), results in the synthesis of a novel fusion protein, API2-MALT1. Until now, no common mechanism of action has been proposed to explain how the products of these seemingly unrelated translocations may contribute to the same malignant process. We show here that Bcl10 and MALT1 form a strong and specific complex within the cell, and that these proteins synergize in the activation of NF-κB. The data support a mechanism of action whereby Bcl10 mediates the oligomerization and activation of the MALT1 caspase-like domain. This subsequently activates the IKK complex through an unknown mechanism, setting in motion a cascade of events leading to NF-κB induction. Furthermore, the API2-MALT1 fusion protein also strongly activates NF-κB and shows dependence upon the same downstream signaling factors. We propose a model whereby both the Bcl10-MALT1 complex and the API2-MALT1 fusion protein activate a common downstream signaling pathway that originates with the oligomerization-dependent activation of the MALT1 caspase-like domain.
AB - At least two distinct recurrent chromosomal translocations have been implicated in the pathogenesis of MALT lymphoma. The first, t(1;14), results in the transfer of the entire Bcl10 gene to chromosome 14 wherein Bcl10 expression is inappropriately stimulated by the neighboring Ig enhancer. The second, t(11;18), results in the synthesis of a novel fusion protein, API2-MALT1. Until now, no common mechanism of action has been proposed to explain how the products of these seemingly unrelated translocations may contribute to the same malignant process. We show here that Bcl10 and MALT1 form a strong and specific complex within the cell, and that these proteins synergize in the activation of NF-κB. The data support a mechanism of action whereby Bcl10 mediates the oligomerization and activation of the MALT1 caspase-like domain. This subsequently activates the IKK complex through an unknown mechanism, setting in motion a cascade of events leading to NF-κB induction. Furthermore, the API2-MALT1 fusion protein also strongly activates NF-κB and shows dependence upon the same downstream signaling factors. We propose a model whereby both the Bcl10-MALT1 complex and the API2-MALT1 fusion protein activate a common downstream signaling pathway that originates with the oligomerization-dependent activation of the MALT1 caspase-like domain.
UR - http://www.scopus.com/inward/record.url?scp=0035374349&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035374349&partnerID=8YFLogxK
U2 - 10.1074/jbc.M009984200
DO - 10.1074/jbc.M009984200
M3 - Article
C2 - 11262391
AN - SCOPUS:0035374349
SN - 0021-9258
VL - 276
SP - 19012
EP - 19019
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 22
ER -